Acute Liver Failure

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 2005 Mar 8

PMID 15749789

Citations 60

Authors

J G OGrady

Affiliations

Soon will be listed here.

Abstract

Acute liver failure is a complex multisystemic illness that evolves quickly after a catastrophic insult to the liver leading to the development of encephalopathy. The underlying aetiology and the pace of progression strongly influence the clinical course. The commonest causes are paracetamol, idiosyncratic drug reactions, hepatitis B, and seronegative hepatitis. The optimal care is multidisciplinary and up to half of the cases receive liver transplants, with survival rates around 75%-90%. Artificial liver support devices remain unproven in efficacy in acute liver failure.

Citing Articles

Hepatoprotective Activity of Nature-Derived Polyphenols Studied by Mass Spectrometry Based Multi-OMICS Approach.

Brzhozovskiy A, Semenov S, Zherebker A, Bugrova A, Yurova M, Zhernov Y Int J Mol Sci. 2025; 26(4).

PMID: 40004070 PMC: 11855638. DOI: 10.3390/ijms26041604.

Nutraceutical Potential of Djulis () Hull: Phytochemicals, Antioxidant Activity, and Liver Protection.

Huang Y, Tung C, Ho S, Li W, Li S, Tung Y Antioxidants (Basel). 2024; 13(6).

PMID: 38929160 PMC: 11201270. DOI: 10.3390/antiox13060721.

Liver Transplantation for Acute Liver Failure- Indication, Prioritization, Timing, and Referral.

Biswas S, Shalimar J Clin Exp Hepatol. 2023; 13(5):820-834.

PMID: 37693253 PMC: 10483009. DOI: 10.1016/j.jceh.2023.01.008.

Pediatric Acute Liver Failure as Presentation of Autoimmune Hepatitis: Learning from a Fatal Case.

Massabki L, Sandy N, De Tommaso A, Brandao M, Hessel G, Lomazi E JPGN Rep. 2023; 3(1):e151.

PMID: 37168764 PMC: 10158326. DOI: 10.1097/PG9.0000000000000151.

Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment.

Hrynkiewicz R, Niedzwiedzka-Rystwej P Front Immunol. 2023; 14:1153528.

PMID: 37153560 PMC: 10160486. DOI: 10.3389/fimmu.2023.1153528.

References

Jalan R, O Damink S, Deutz N, Lee A, Hayes P . Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999; 354(9185):1164-8. DOI: 10.1016/s0140-6736(98)12440-6. View

Chen S, Mullon C, Kahaku E, Watanabe F, HEWITT W, Eguchi S . Treatment of severe liver failure with a bioartificial liver. Ann N Y Acad Sci. 1998; 831:350-60. DOI: 10.1111/j.1749-6632.1997.tb52210.x. View

Strauss G, Knudsen G, Kondrup J, Moller K, Larsen F . Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology. 2001; 121(5):1109-19. DOI: 10.1053/gast.2001.29310. View

Bernal W, Donaldson N, Wyncoll D, Wendon J . Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002; 359(9306):558-63. DOI: 10.1016/S0140-6736(02)07743-7. View

Harry R, Auzinger G, Wendon J . The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology. 2002; 36(2):395-402. DOI: 10.1053/jhep.2002.34514. View

Bernal W . Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis. 2003; 23(3):227-37. DOI: 10.1055/s-2003-42640. View

Murphy N, Auzinger G, Bernel W, Wendon J . The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004; 39(2):464-70. DOI: 10.1002/hep.20056. View

Gimson A, Braude S, Mellon P, Canalese J, Williams R . Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982; 2(8300):681-3. DOI: 10.1016/s0140-6736(82)90711-5. View

OGrady J, Gimson A, OBrien C, Pucknell A, Hughes R, Williams R . Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988; 94(5 Pt 1):1186-92. DOI: 10.1016/0016-5085(88)90011-x. View

10.

OGrady J, Alexander G, Hayllar K, Williams R . Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97(2):439-45. DOI: 10.1016/0016-5085(89)90081-4. View

11.

Blei A, Olafsson S, Webster S, Levy R . Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993; 341(8838):157-8. DOI: 10.1016/0140-6736(93)90016-a. View

12.

OGrady J, Schalm S, Williams R . Acute liver failure: redefining the syndromes. Lancet. 1993; 342(8866):273-5. DOI: 10.1016/0140-6736(93)91818-7. View

13.

Keays R, Alexander G, Williams R . The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol. 1993; 18(2):205-9. DOI: 10.1016/s0168-8278(05)80247-8. View

14.

Davenport A . The management of renal failure in patients at risk of cerebral edema/hypoxia. New Horiz. 1995; 3(4):717-24. View

15.

Ellis A, Hughes R, Wendon J, Dunne J, Langley P, Kelly J . Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996; 24(6):1446-51. DOI: 10.1002/hep.510240625. View

16.

Clemmesen J, Larsen F, Ejlersen E, Schiodt F, Ott P, Hansen B . Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Eur J Gastroenterol Hepatol. 1997; 9(1):55-60. DOI: 10.1097/00042737-199701000-00014. View

17.

Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R . The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000; 32(4 Pt 1):734-9. DOI: 10.1053/jhep.2000.17687. View